ATE460482T1 - Fas-liganden derivate - Google Patents

Fas-liganden derivate

Info

Publication number
ATE460482T1
ATE460482T1 AT98943025T AT98943025T ATE460482T1 AT E460482 T1 ATE460482 T1 AT E460482T1 AT 98943025 T AT98943025 T AT 98943025T AT 98943025 T AT98943025 T AT 98943025T AT E460482 T1 ATE460482 T1 AT E460482T1
Authority
AT
Austria
Prior art keywords
fas ligand
ligand derivatives
fas
apoptosis
derivatives
Prior art date
Application number
AT98943025T
Other languages
English (en)
Inventor
Shigekazu Nagata
Masato Tanaka
Original Assignee
Mochida Pharm Co Ltd
Osaka Bioscience Inst
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mochida Pharm Co Ltd, Osaka Bioscience Inst filed Critical Mochida Pharm Co Ltd
Application granted granted Critical
Publication of ATE460482T1 publication Critical patent/ATE460482T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/70575—NGF/TNF-superfamily, e.g. CD70, CD95L, CD153, CD154
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/525—Tumour necrosis factor [TNF]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Toxicology (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Cell Biology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
AT98943025T 1997-09-17 1998-09-17 Fas-liganden derivate ATE460482T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP25254197 1997-09-17
PCT/JP1998/004187 WO1999014325A1 (fr) 1997-09-17 1998-09-17 NOUVEAU DERIVE DU LIGAND Fas

Publications (1)

Publication Number Publication Date
ATE460482T1 true ATE460482T1 (de) 2010-03-15

Family

ID=17238817

Family Applications (1)

Application Number Title Priority Date Filing Date
AT98943025T ATE460482T1 (de) 1997-09-17 1998-09-17 Fas-liganden derivate

Country Status (7)

Country Link
US (1) US6951919B1 (de)
EP (1) EP1016721B1 (de)
JP (1) JP4162849B2 (de)
AT (1) ATE460482T1 (de)
CA (1) CA2304130C (de)
DE (1) DE69841548D1 (de)
WO (1) WO1999014325A1 (de)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7070771B1 (en) 1996-12-09 2006-07-04 Regents Of The University Of California Methods of expressing chimeric mouse and human CD40 ligand in human CD40+ cells
US20030044352A1 (en) * 2001-04-24 2003-03-06 Phillips Nigel C. Method for evaluating the efficacy of treatment with bacterial DNA and bacterial cell walls
US7786282B2 (en) 2001-12-06 2010-08-31 The Regents Of The University Of California Nucleic acid molecules encoding TNF-α ligand polypeptides having a CD154 domain
US7495090B2 (en) 2002-05-23 2009-02-24 The Regents Of The University Of California Nucleic acids encoding chimeric CD154 polypeptides
JP2009538615A (ja) * 2006-05-31 2009-11-12 スティックス エルエルシー 幹細胞の選別方法およびその使用
EP2595637B1 (de) 2010-07-22 2017-11-01 Cellect Biotherapeutics Ltd. Immunregulatorische zellen mit verstärkter gezielter zelltodwirkung
WO2012042480A1 (en) 2010-09-28 2012-04-05 Kahr Medical Ltd. Compositions and methods for treatment of hematological malignancies
EP4452298A4 (de) * 2021-12-22 2025-11-19 Memorial Sloan Kettering Cancer Center Zellen zur expression von fas-liganden und cflip-polypeptiden und verwendungen davon
WO2023122235A2 (en) * 2021-12-22 2023-06-29 Memorial Sloan-Kettering Cancer Center Cells expressing fas ligand polypeptides and fas knockout and uses thereof

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH09124510A (ja) 1995-10-27 1997-05-13 Sumitomo Electric Ind Ltd Ｆａｓリガンドの遊離抑制剤及び抑制方法
US6495520B2 (en) * 1996-03-22 2002-12-17 Human Genome Sciences, Inc. Apoptosis Inducing Molecule II and methods of use
US6479254B2 (en) * 1996-03-22 2002-11-12 Human Genome Sciences, Inc. Apoptosis inducing molecule II
US6544523B1 (en) 1996-11-13 2003-04-08 Chiron Corporation Mutant forms of Fas ligand and uses thereof
US6183951B1 (en) * 1997-04-11 2001-02-06 Prometheus Laboratories, Inc. Methods of diagnosing clinical subtypes of crohn's disease with characteristic responsiveness to anti-Th1 cytokine therapy

Also Published As

Publication number Publication date
CA2304130A1 (en) 1999-03-25
JP4162849B2 (ja) 2008-10-08
EP1016721A4 (de) 2004-12-01
CA2304130C (en) 2008-10-28
EP1016721B1 (de) 2010-03-10
WO1999014325A1 (fr) 1999-03-25
EP1016721A1 (de) 2000-07-05
DE69841548D1 (de) 2010-04-22
US6951919B1 (en) 2005-10-04

Similar Documents

Publication Publication Date Title
WO1999003822A8 (en) Bicyclic metabotropic glutamate receptor ligands
DE60239097D1 (de) Drei-hybrid-assaysystem
PT960107E (pt) Compostos de paclitaxel 6-tio-substituidos
ATE350409T1 (de) Ampholytisches copolymer und dessen verwendung
EP0956029A4 (de) Zyklische peptide mit breitspektrum antimikrobieller aktivität
TR199801804A3 (tr) Kaydirma rayi tetik takimi.
MXPA04002404A (es) Ligandos novedosos para los sitios hisb10zn2+ del hexamero de insulina en estado r.
DE69716925D1 (de) Isoxazoline derivate und ihre verwendung als antimikroben
ID23374A (id) Halogenopirimidin
ATE273956T1 (de) Arylsubstituierte olefinische amine und ihre verwendung als cholinergische rezeptoragonisten
BRPI0112375B8 (pt) aplidinas como derivados antitumorais
ATE347590T1 (de) Kurze peptide die die aktivität serine/threonine kinasen modulieren
ATE460482T1 (de) Fas-liganden derivate
GB9815618D0 (en) Treatment of dyskinesia
ATE390482T1 (de) Interleukin-1 hy2. mittel und verfahren
PT971922E (pt) Compostos de tetra-hidropirido
DE69628458D1 (de) 25-hydroxy-16-ene-26,27-bishome-cholecalceriferol derivate
TR200001622T2 (tr) Asilatlı Hetero-Alisiklik Türevleri
ITBO990692A0 (it) Gamba stabilizzatrice per veicoli da lavoro .
DE502004004808D1 (de) Proteinbindende derivate von platinkomplexen mit cyclobutan-1,1-dicarboxylatliganden
TR200003203T2 (tr) Karboksaldehitin saflaştırılması
PT1011329E (pt) Paclitaxeis de 7-metiltio-oxometilo e 7-metiltiodioxometilo
MXPA04005226A (es) 1,3-diarilprop-2-en-1-onas, composiciones que las contienen y su utilizacion.
NO20020064L (no) Chlamysin B antibakterielt protein, gen som koder for dette samt et ekspresjonssystem for dette
DE60014858D1 (de) Neue bioanalyse

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties